@article{HerwegHansmeierOttoetal.2015,
  author    = {Herweg, Jo-Ana and Hansmeier, Nicole and Otto, Andreas and Geffken, Anna C. and Subbarayal, Prema and Prusty, Bhupesh K. and Becher, D{\"o}rte and Hensel, Michael and Schaible, Ulrich E. and Rudel, Thomas and Hilbi, Hubert},
  title     = {Purification and proteomics of pathogen-modified vacuoles and membranes},
  series = {Frontiers in Cellular and Infection Microbiology},
  volume    = {5},
  journal   = {Frontiers in Cellular and Infection Microbiology},
  number    = {48},
  doi       = {10.3389/fcimb.2015.00048},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-151823},
  year      = {2015},
  abstract  = {Certain pathogenic bacteria adopt an intracellular lifestyle and proliferate in eukaryotic host cells. The intracellular niche protects the bacteria from cellular and humoral components of the mammalian immune system, and at the same time, allows the bacteria to gain access to otherwise restricted nutrient sources. Yet, intracellular protection and access to nutrients comes with a price, i.e., the bacteria need to overcome cell-autonomous defense mechanisms, such as the bactericidal endocytic pathway. While a few bacteria rupture the early phagosome and escape into the host cytoplasm, most intracellular pathogens form a distinct, degradation-resistant and replication-permissive membranous compartment. Intracellular bacteria that form unique pathogen vacuoles include Legionella, Mycobacterium, Chlamydia, Simkania, and Salmonella species. In order to understand the formation of these pathogen niches on a global scale and in a comprehensive and quantitative manner, an inventory of compartment-associated host factors is required. To this end, the intact pathogen compartments need to be isolated, purified and biochemically characterized. Here, we review recent progress on the isolation and purification of pathogen-modified vacuoles and membranes, as well as their proteomic characterization by mass spectrometry and different validation approaches. These studies provide the basis for further investigations on the specific mechanisms of pathogen-driven compartment formation.},
  language  = {en}
}
@phdthesis{Herweg2018,
  author    = {Herweg, Jo-Ana},
  title     = {Die Simkania-Vakuole: Die Rolle von ER, retro-/anterograden Protein- und Lipidtransport},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-136844},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2018},
  abstract  = {Simkania negevensis (Sn) is a Chlamydia-like obligate intracellular bacterium which replicates within a membrane bound vacuole, termed SCV (Simkania-containing vacuole). The SCV is a unique compartment closely associated with ER-membranes, consequently ER-stress is blocked by the bacteria. SCV morphology is similar among epithelial cells (HeLa229, A549, HEp-2) and macrophages (THP1). The SCV represents the first intracellular interface between the host and pathogen which serves as a replication niche. Identifying human and bacterial factors associated with ER-SCV-membranes should contribute towards the understanding of SCV composition and formation as well as interactions with ER or transports. Comparative studies of the SCV should indicate similarities to the chlamydial inclusion since some host cell factors are already known for Chlamydia. In this thesis, a purification protocol has been established that is applicable to HeLa229 and THP1 ER-SCV-membranes and has been further utilized for proteome and lipidome analyses. 302 bacterial and 1178 human proteins composing ER-SCV-membranes and 885 bacterial proteins composing purified Sn have been identified by using label-free mass spectrometry measurements. Among the human factors of non or Sn infected ER-(SCV-) membranes we found 51 enriched or depleted proteins in addition to 57 transport associated ones that indicated infection induced differences among intracellular protein transport. Contrary regulation of retrograde and anterograde transported proteins could be confirmed by using RNA interference and inhibitor tests, whereby Clathrin-associated and COPI vesicles seem to play a central role. Application of Retro-inhibitors, which interfered with retrograde transport processes between endosome to Golgi or early to late endosomes, as well as Bafilomycin A1 (retrograde, late endosomes and lysosomes) and Brefeldin A (anterograde, ER and Golgi) exerted a strong influence on SCV formation, morphology and intracellular lipid transport. By using label-free mass spectrometry measurements and thin layer chromatography we could determine differences in lipid levels within Sn infected cells, ER-SCV-membranes and purified Sn in comparison to uninfected cells. In addition to lipid enrichment or depletion in whole-cell extracts and ER-SCV-membranes, we identified two infection-specific lipids, cholesterol-ß-Dglucoside and PE 30:0. Further, high-throughput RNA interference tests indicated a dependence of Sn infections on endosome to Golgi and Clathrin-associated vesicle transports. Taken together, we were able to identify initial potential SCV-associated proteins and lipids that were connected to bacterial infection. Furthermore, SCV formation and Sn infectiousness depends on retrograde transport processes and therefore also on acquisition of nutrients, such as lipids.},
  subject      = {Simkania},
  language  = {de}
}
@article{WuPonsGoudetetal.2017,
  author    = {Wu, Yu and Pons, Val{\´e}rie and Goudet, Am{\´e}lie and Panigai, Laetitia and Fischer, Annette and Herweg, Jo-Ana and Kali, Sabrina and Davey, Robert A. and Laporte, J{\´e}r{\^o}me and Bouclier, C{\´e}line and Yousfi, Rahima and Aubenque, C{\´e}line and Merer, Goulven and Gobbo, Emilie and Lopez, Roman and Gillet, Cynthia and Cojean, Sandrine and Popoff, Michel R. and Clayette, Pascal and Le Grand, Roger and Boulogne, Claire and Tordo, No{\"e}l and Lemichez, Emmanuel and Loiseau, Philippe M. and Rudel, Thomas and Sauvaire, Didier and Cintrat, Jean-Christophe and Gillet, Daniel and Barbier, Julien},
  title     = {ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments},
  series = {Scientific Reports},
  volume    = {7},
  journal   = {Scientific Reports},
  doi       = {10.1038/s41598-017-15466-7},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-173170},
  year      = {2017},
  abstract  = {Intracellular pathogenic microorganisms and toxins exploit host cell mechanisms to enter, exert their deleterious effects as well as hijack host nutrition for their development. A potential approach to treat multiple pathogen infections and that should not induce drug resistance is the use of small molecules that target host components. We identifed the compound 1-adamantyl (5-bromo-2-methoxybenzyl) amine (ABMA) from a cell-based high throughput screening for its capacity to protect human cells and mice against ricin toxin without toxicity. This compound efciently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite. ABMA provokes Rab7-positive late endosomal compartment accumulation in mammalian cells without affecting other organelles (early endosomes, lysosomes, the Golgi apparatus, the endoplasmic reticulum or the nucleus). As the mechanism of action of ABMA is restricted to host-endosomal compartments, it reduces cell infection by pathogens that depend on this pathway to invade cells. ABMA may represent a novel class of broad-spectrum compounds with therapeutic potential against diverse severe infectious diseases.},
  language  = {en}
}